Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion type Assertion NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_head.
- NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion description "[Individuals with Tangier disease also have elevated plasma TG concentrations and a near absence of HDL, resulting from mutations in ATP binding cassette transporter A1 (ABCA1), which facilitates the efflux of cellular phospholipid and free cholesterol to assemble with apolipoprotein A-I (apoA-I), forming nascent HDL particles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_provenance.
- NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion evidence source_evidence_literature NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_provenance.
- NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion SIO_000772 22001232 NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_provenance.
- NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion wasDerivedFrom befree-20140225 NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_provenance.
- NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_assertion wasGeneratedBy ECO_0000203 NP500279.RAepoKpLK4GrxUaYc1L6ODlBcLex_lXMSbNnWdwZYJ0Gw130_provenance.